DC Field | Value | Language |
dc.contributor.author | Malic, Alina | |
dc.contributor.author | Lesnic, Evelina | |
dc.date.accessioned | 2021-12-13T13:53:12Z | |
dc.date.available | 2021-12-13T13:53:12Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | MALIC, Alina, LESNIC, Evelina. The effect of diabetes mellitus on evolution and outcome of tuberculosis in a prospective study. In: The Moldovan Medical Journal. 2021, vol. 64, no 5, pp. 5-10. ISSN 2537-6381. https://doi.org/10.52418/moldovan-med-j.64-5.21.03 | |
dc.identifier.issn | 2537-6381 | |
dc.identifier.issn | 2537-6373 | |
dc.identifier.uri | http://moldmedjournal.md/wp-content/uploads/2021/12/Moldovan-Med-Journal-November-Vol-64-No-5-sp4.pdf | |
dc.identifier.uri | https://doi.org/10.52418/moldovan-med-j.64-5.21.03 | |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/19386 | |
dc.description | Department of Pneumophthisiology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, the Republic of Moldova | en_US |
dc.description.abstract | Background: In the Republic of Moldova almost 5% of the cases with tuberculosis are diagnosed annually among diabetic patients. The aim of this study
was to assess the impact of diabetes mellitus on the evolution and anti-tuberculosis treatment effectiveness in a prospective study.
Material and methods: A prospective, longitudinal and case-control study, which included a total number of 252 patients diagnosed with pulmonary
tuberculosis and distributed in a study group, consisting of 93 patients diagnosed with diabetes mellitus and a control group, consisting of 159 patients
without glycemic disorders, was performed.
Results: This study identified that one half of the group with diabetes was detected by active screening and one third received anti-tuberculous treatment
before actual episode. A similar rate of diabetic and non-diabetic patients was microbiologically positive, as well confirmed with drug-resistance. The
anti-tuberculous treatment effectiveness was lower in diabetic patients, the death rate and the low treatment outcome (lost to follow-up and failed) were
higher than in non-diabetic patients. The main causes of unfavorable evolution were: glycemic disorders (hyperglycemia), diabetes complications and
the history of the anti-tuberculous treatment in the anamnesis.
Conclusions: The individualized approach and a tight follow-up should be performed regularly in all patients with glycemic disorders and tuberculosis
for the improvement of the disease outcome. | en_US |
dc.language.iso | en | en_US |
dc.publisher | The Scientific Medical Association of the Republic of Moldova | en_US |
dc.relation.ispartof | The Moldovan Medical Journal: The Annual Scientific Conference of Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova on the occasion of the 76 years of activity: Research in biomedicine and health quality, excellence and performance, 20-22 October 2021 | en_US |
dc.subject | tuberculosis | en_US |
dc.subject | diabetes | en_US |
dc.subject | risk factors | en_US |
dc.subject | outcome | en_US |
dc.subject.ddc | UDC: 616.379-008.64:616.24-002.5 | en_US |
dc.title | The effect of diabetes mellitus on evolution and outcome of tuberculosis in a prospective study | en_US |
dc.type | Article | en_US |
Appears in Collections: | The Moldovan Medical Journal. Vol. 64, No 5, November 2021
|